Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: No added diagnostic value of non-phosphorylated tau fraction (p-taurel) in CSF as a biomarker for differential dementia diagnosis

Fig. 2

Dot plots of individual markers and ratios. Dot plots showing individual biomarker levels in each subgroup. a amyloid-beta of 42 amino acids ( 1–42 ); b total tau protein (t-tau); c tau protein phosphorylated at threonine 181(p-tau 181 ); d non-phosphorylated tau fraction (p-tau rel ); e1–42/t-tau; f1–42/p-tau181; g1–42/p-taurel; h p-tau181/t-tau; i p-tau181/p-taurel. Lines indicate median with interquartile range. AD Alzheimer’s disease, CJD Creutzfeldt-Jakob disease, DLB dementia with Lewy bodies, FTLD frontotemporal lobar degeneration

Back to article page